Alejandro Llanos‐Cuentas

Single-Dose Tafenoquine to Prevent Relapse of <i>Plasmodium vivax</i> Malaria

Marcus Lacerda, Alejandro Llanos‐Cuentas, Srivicha Krudsood et al. · New England Journal of Medicine · 2019 · 277 citations · Full text

Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study

Alejandro Llanos‐Cuentas, Marcus Lacerda, Ronnatrai Rueangweerayut et al. · The Lancet · 2013 · 242 citations

Antiparasitic Agent, Medicine, Malaria +6

Influence of<i>Leishmania (Viannia)</i>Species on the Response to Antimonial Treatment in Patients with American Tegumentary Leishmaniasis

Jorge Arévalo, Luis Ramirez, Vanessa Adaui et al. · The Journal of Infectious Diseases · 2007 · 241 citations · Full text

Tafenoquine versus Primaquine to Prevent Relapse of <i>Plasmodium vivax</i> Malaria

Alejandro Llanos‐Cuentas, Marcus Lacerda, Tran Tinh Hien et al. · New England Journal of Medicine · 2019 · 239 citations · Full text

A Randomized, Double-Blind, Parallel-Group, Dose-Response Study of Micafungin Compared with Fluconazole for the Treatment of Esophageal Candidiasis in HIV-Positive Patients

N. de Wet, Alejandro Llanos‐Cuentas, Jamal Suleiman et al. · Clinical Infectious Diseases · 2004 · 205 citations · Full text